bromodeoxyuridine has been researched along with Glioma in 121 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 36 (29.75) | 18.7374 |
1990's | 51 (42.15) | 18.2507 |
2000's | 24 (19.83) | 29.6817 |
2010's | 10 (8.26) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, CG; Li, DH; Liu, Y; Xiao, LM; Xu, CH; Zeng, EM; Zheng, SY | 1 |
Cairncross, G; Döring, A; Dunn, JF; Forsyth, P; Hader, W; Hamilton, M; Kelly, J; Kinniburgh, D; Lun, X; Mercier, P; Robbins, S; Sarkar, S; Silva, C; van Rooijen, N; Wang, X; Weiss, S; Yong, VW; Zemp, FJ | 1 |
Dello Russo, C; Laudati, E; Lisi, L; Navarra, P | 1 |
Massey, AJ | 1 |
Corde, S; Konstantinov, K; Lerch, ML; Oktaria, S; Rosenfeld, AB; Tehei, M | 1 |
Alonso-Basanta, M; Devitt, ML; Esencay, M; Formenti, SC; Lukyanov, Y; McBride, W; Newcomb, EW; Schnee, T; Shao, Y; Smirnova, I; Zagzag, D | 1 |
Akev, N; Bilir, A; Erguven, M; Karabulut, E; Ozdemir, A | 1 |
Cakiroglu, M; Caldeira, M; Laywell, ED; Levkoff, LH; Mariani, CL; Marshall, GP; Reynolds, BA; Ross, HH; Streit, WJ | 1 |
Arregui, L; Benítez, JA; Cabrera, G; Segovia, J | 1 |
Consoli, GM; Drago, F; Geraci, C; Merlo, S; Sortino, MA; Viola, S | 1 |
Heth, J; Hoff, JT; Hua, Y; Keep, RF; Muraszko, KM; Tang, L; Xi, G | 1 |
Heneka, MT; Hermes, M; Kummer, MP; Orlandi, M; Papi, A; Tatenhorst, L; Terwel, D | 1 |
Dar, DE; Stall, N; Taliaz, D; Zangen, A | 1 |
Chen, FX; Duan, Y; Ji, Y; Qian, Y; Ren, WW; Shen, D; Xu, S; Yang, Y; Zong, Y | 1 |
Beaudet, MJ; Kobinger, GP; Rueda, N; Vallières, L; Villeneuve, J | 1 |
Cho, KG; Kim, JH; Kim, SU; Lee, JE | 1 |
Hu, JG; Li, XW; Lü, HZ; Wang, FC; Wang, XF; Zhou, JS | 1 |
Bruce, JN; Canoll, P; Castelli, M; Ellis, JA; Ogden, AT | 1 |
Howard, SP; Rajesh, D; Stenzel, RA | 1 |
Chou, RC; Langan, TJ | 1 |
Gorin, F; Harley, W; Jue, T; Lyeth, B; Schnier, J | 1 |
Lehnert, S; Li, Y; Owusu, A | 1 |
Cameron, RE; Dragunow, M; Gray, CW; Lim, J; Lind, CR; Narayan, PJ; O'Carroll, SJ; Pearson, AG | 1 |
Aubert, M; Badoual, M; Christov, C; Féreol, S; Grammaticos, B | 1 |
Beck, M; Feinstein, DL; Grommes, C; Heneka, MT; Jacobs, AH; Landreth, GE; Sastre, M; Schlegel, U | 1 |
Adamczyk, A; Gasinska, A; Glinski, B; Krzyszkowski, T; Niemiec, J; Skolyszewski, J; Zabek, M | 1 |
Alberta, JA; Anderson, DJ; Bachoo, RM; Depinho, RA; Huillard, E; Kane, M; Kesari, S; Ligon, KL; Liu, H; Louis, DN; Mehta, S; Rowitch, DH; Stiles, CD | 1 |
Colombatto, S; Grillo, MA; Heidegger, W; Hermann, A; Kainz, V; Weiger, TM | 1 |
Bengzon, J; Bexell, D; Gunnarsson, S; Nordquist, J | 1 |
Barone, TA; DeChant, A; Hoffer, A; Lock, J; Mangla, S; Miller, RH; Morrow, J; Plunkett, RJ; Selkirk, SM | 1 |
Aktas, E; Bilir, A; Bonavida, B; Erguven, M; Oktem, G; Ozdemir, A; Uslu, A | 1 |
Hoshino, T; Nagai, M; Sano, K; Sato, F; Tsuchida, T | 1 |
Sano, K | 2 |
Hugues, P; Montaudon, D; Robert, J | 1 |
Hoshino, T; Nagashima, T | 1 |
Levin, EM; Levin, VA; Phuphanich, S | 1 |
Collins, J; Gianni, L; Glatstein, E; Jenkins, J; Kinsella, TJ; Klecker, RW; Mitchell, JB; Myers, C; Rowland, J; Russo, A | 1 |
Hayashi, J; Tagashira, Y; Watanabe, T; Yoshida, MC | 1 |
Handa, J; Matsumura, K; Nakajima, M; Nakasu, S; Nioka, H | 1 |
Davis, RL; Hoshino, T; Onda, K; Shibuya, M; Wilson, CB | 1 |
Kurihara, H; Matsuzaki, S; Sugimoto, H; Tamura, M; Tsukahara, T; Yamazaki, H | 1 |
Freese, A; Judy, K; O'Connor, MJ; O'Rourke, D | 1 |
Devi, NK; Kalia, VK | 1 |
Greenberg, HS; Lawrence, TS; Mancini, WR; McLaughlin, PW; Nguyen, N; Seabury, H; Stetson, PL | 1 |
Bromberg, J; Chandler, WF; Crane, D; Ensminger, WD; Greenberg, HS; Junck, L; McKeever, P; Page, MA; Sandler, H; Tankanow, R | 1 |
Brown, SL; Freytag, SO; Kim, JH; Kim, SH | 1 |
Ahn, DK; Davis, RL; Hoshino, T; Prados, MD; Wacker, MR | 1 |
Aoyagi, M; Hirakawa, K; Nagano, N; Sasaki, H | 1 |
Endo, K; Hirano, T; Inoue, T; Ohye, C; Oriuchi, N; Shibazaki, T; Tamura, M; Tateno, M; Tomiyoshi, K; Watanabe, N | 1 |
Greenberg, HS; Heidorn, DB; Lawrence, TS; Mancini, WR; McLaughlin, PW; Nguyen, N; Seabury, H; Stetson, PL | 1 |
Asai, A; Bodell, WJ; Hirai, H; Hoshino, T | 1 |
Davis, RL; Hoshino, T; Lamborn, K; Onda, K; Shubuya, M | 1 |
Ishihara, H; Ito, H; Mimura, Y; Murakami, T; Nishizaki, T; Ohshita, N | 1 |
Bottone, MG; Danova, M; Mangiarotti, R; Pellicciari, C; Wang, E | 1 |
Diksic, M; Takeda, N; Yamamoto, YL | 1 |
Danova, M; Dionigi, P; Ferrari, C; Giordano, M; Mazzini, G; Riccardi, A | 1 |
Shigematsu, H | 1 |
Inglis, BA; Johnson, J; Maria, BL; Muir, D; Rojiani, A; Rojiani, M | 1 |
Brunberg, JA; Greenberg, HS; Junck, L; McKeever, PE; Ross, DA; Strawderman, MS | 1 |
Battermann, JJ; Jansen, GH; Rutgers, DH; Struikmans, H; Tulleken, CA; van der Tweel, I | 1 |
Asbell, S; Comis, R; Curran, W; Davis, RL; Lamborn, K; Levin, VA; Murray, K; Nelson, J; Phillips, TL; Prados, MD; Rotman, M; Rubin, P; Sause, W; Scott, CB | 1 |
Halfter, H; Lotfi, R; Ringelstein, EB; Stögbauer, FT; Westermann, R; Young, P | 1 |
Chiba, Y; Hara, M; Kamada, H; Murakami, H; Ohshima, TA; Saito, I; Sawa, H; Ukita, H | 1 |
Inubushi, T; Morikawa, S; Nakajima, M; Nakasu, S | 1 |
Davis, RL; Kaplan, SB; Lamborn, KR; Prados, MD | 1 |
Glaze, ER; Greenberg, HS; Mancini, WR; Stetson, PL | 1 |
Karak, AK; Mehta, VS; Sarkar, C; Schmitt, HP; Sharma, S; Singh, R | 1 |
Battermann, JJ; Dullens, HF; Jansen, GH; Oosten, L; Rutgers, DH; Struikmans, H; Tulleken, CA; van der Tweel, I | 1 |
Humpel, C; Weis, C; Wiesenhofer, B | 1 |
Altaner, C; Hlavatý, J; Hlubinová, K | 1 |
Asai, A; Hamada, H; Kirino, T; Sakurai, S; Shibasaki, F; Shinoura, N | 1 |
Goldstein, MN; Kolber, AR; Moore, BW; Perumal, AS | 1 |
Cook, JA; Epstein, AH; Glatstein, E; Goffman, T | 1 |
Cogen, PH; Davis, RL; Edwards, MS; Hoshino, T; Krouwer, HG; Prados, MD | 1 |
Hoshino, T | 3 |
Izumi, I; Kowada, M; Mineura, K; Watanabe, K | 1 |
Hoshino, T; Maeda, T | 1 |
Ellero, J; Ensminger, WD; Mancini, WR; Shewach, DS | 1 |
Merchant, RE; Rice, CD | 1 |
Hara, A; Hirayama, H; Mori, H; Niikawa, S; Ohno, T; Sakai, N; Tanaka, T; Yamada, H | 1 |
Brem, SS; Brien, SE; Elkouby, MP; Gately, S; Tsanaclis, AM; Zagzag, D | 1 |
Asai, A; Davis, RL; Dodson, BA; Hoshino, T; Ito, S; Prados, MD; Shibuya, M; Wilson, CB | 1 |
Endo, K; Hirano, T; Igarashi, H; Inoue, T; Oriuchi, N; Shibazaki, T; Tamura, M; Tateno, M; Tomiyoshi, K; Watanabe, N | 1 |
Ensminger, WD; Greenberg, HS; Lawrence, TS; Mancini, WR; Stetson, PL; Wagner, JG | 1 |
Berens, ME; Jung, HW; Krouwer, HG; Rosenblum, ML | 1 |
Aritake, K; Asai, A; Fujimaki, T; Fukushima, T; Funada, N; Houjo, S; Koike, M; Matsutani, M; Nakamura, O; Segawa, H | 1 |
Boyd, JC; Herman, MM; Ibayashi, N; Rubinstein, LJ | 1 |
Averill, D; Greenberg, HS; Hegarty, TJ; Junck, L; Kincaid, MC; Page, M; Vander, JF | 1 |
Chandler, WF; Ensminger, W; Greenberg, HS; Junck, L; McKeever, PE; Mukhopadhyay, SK | 1 |
Detta, A; Hitchcock, E | 1 |
Asai, A; Barker, M; Gray, JW; Hoshino, T; Shibui, S; Vanderlaan, M | 1 |
Assietti, R; Butti, G; Danova, M; Gaetani, P; Magrassi, L; Riccardi, A | 1 |
Higuchi, O; Hoshino, T; Komatsu, Y; Maki, Y; Matsuki, T; Sugimoto, K; Takeuchi, S; Tsurushima, H; Yamada, Y; Yoshii, Y | 1 |
Fukui, M; Inoue, T; Iwaki, T; Takeshita, I | 1 |
Hoshino, T; Iwasaki, K; Jastreboff, MM; Nomura, K; Shibui, S | 1 |
Kasahara, E; Miyagami, M; Tazoe, M; Tsubokawa, T | 1 |
Cho, KG; Davis, RL; Donegan, J; Hoshino, T; Nagashima, T; Slusarz, M; Wilson, CB | 1 |
Kunimine, H; Niibe, H; Tamaki, Y; Tamura, M; Tsukahara, T; Zama, A | 1 |
Hayashi, M; Ishii, H; Ishii, Y; Kawano, H; Nakatsugawa, S; Satoh, K | 1 |
Gray, JW; Hoshino, T; Shibui, S; Vanderlaan, M | 1 |
Nagashima, T; Takakura, K | 1 |
Cho, KG; Davis, RL; Germano, IM; Hoshino, T; Ito, M; Wilson, CB | 1 |
Morimura, T | 1 |
DeArmond, SJ; Hoshino, T; Murovic, J; Nagashima, T | 1 |
Gutin, PH; Nelson, DF; Saunders, WM; Sheline, GE; Urtasun, RC | 1 |
Genka, S; Kosugi, Y; Shitara, N; Takakura, K; Tsujita, Y | 1 |
Albers, GW; Forno, LS; Hoyt, WF; Shratter, LA | 1 |
Genka, S; Kosugi, Y; Shitara, N; Takakura, K; Tsujita, Y; Wu, Y | 1 |
Hoshino, T; Nagashima, T; Zhang, RX | 1 |
Kaji, K; Morimura, T | 1 |
Jenssen, J; Syversen, T | 1 |
Davis, RL; DeArmond, SJ; Edwards, MS; Gutin, PH; Hoshino, T; Murovic, JA; Nagashima, T; Wilson, CB | 1 |
Hoshino, T; Nagai, M; Sano, K | 1 |
Breckenridge, BM; Morris, NR; Schwartz, JP | 1 |
Dorfman, A; Galligani, L; Ho, PL; Schwartz, NB | 1 |
Hamprecht, B; Schultz, J | 1 |
Goldstein, MN; Silbert, SW | 1 |
Hatanaka, H | 1 |
8 review(s) available for bromodeoxyuridine and Glioma
Article | Year |
---|---|
Integrative treatment of gliomas.
Topics: Adjuvants, Immunologic; Adult; Boron; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Division; Combined Modality Therapy; Female; Glioma; Humans; Interferons; Isotopes | 1983 |
[A review of cell kinetic studies on brain tumors with special reference to anti-bromodeoxyuridine monoclonal antibody method].
Topics: Animals; Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Separation; DNA; Flow Cytometry; Glioma; Humans; Rats | 1984 |
The application of 5-bromodeoxyuridine in the management of CNS tumors.
Topics: Brain Neoplasms; Bromodeoxyuridine; Glioma; Humans; Meningeal Neoplasms; Meningioma | 1994 |
Cell kinetics of glial tumors.
Topics: Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; DNA, Neoplasm; Glioma; Humans; Kinetics; Neoplasm Invasiveness | 1992 |
[Chemical modifiers in radiotherapy].
Topics: Brain Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Glioma; Humans; Immunologic Factors; Interferon Type I; Nimustine; Radiation-Sensitizing Agents | 1989 |
Recent and current investigations of radiation therapy of malignant gliomas.
Topics: Brachytherapy; Brain; Brain Neoplasms; Bromodeoxyuridine; Carmustine; Glioma; Helium; Humans; Hyperbaric Oxygenation; Hyperthermia, Induced; Mesons; Metronidazole; Middle Aged; Misonidazole; Neon; Neutrons; Radiation-Sensitizing Agents; Radiotherapy; Radiotherapy, High-Energy | 1986 |
Proliferative potential of pediatric brain tumors.
Topics: Adolescent; Adult; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Child; Child, Preschool; Female; Glioma; Humans; Male; Meningioma; Teratoma | 1987 |
[Management of glioma].
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cats; Glioma; Humans; Mice | 1969 |
4 trial(s) available for bromodeoxyuridine and Glioma
Article | Year |
---|---|
Age and bromodeoxyuridine labelling index as prognostic factors in high-grade gliomas treated with surgery and radiotherapy.
Topics: Adult; Age Factors; Aged; Brain Neoplasms; Bromodeoxyuridine; Cell Proliferation; Combined Modality Therapy; Disease Progression; DNA, Neoplasm; Female; Flow Cytometry; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Oxygen; Ploidies; Prognosis; Sensitivity and Specificity; Staining and Labeling; Survival Rate; Treatment Outcome; Tumor Cells, Cultured | 2006 |
Radiosensitization with carotid intra-arterial bromodeoxyuridine +/- 5-fluorouracil biomodulation for malignant gliomas.
Topics: Adult; Aged; Brain Neoplasms; Bromodeoxyuridine; Fluorouracil; Glioma; Humans; Infusions, Intra-Arterial; Middle Aged; Radiation-Sensitizing Agents | 1994 |
Tumour radiosensitization with the halogenated pyrimidines 5'-bromo- and 5'-iododeoxyuridine.
Topics: Brain Neoplasms; Bromodeoxyuridine; Glioma; Head and Neck Neoplasms; Humans; Idoxuridine; Radiation-Sensitizing Agents; Sarcoma | 1992 |
The ocular effects of intracarotid bromodeoxyuridine and radiation therapy in the treatment of malignant glioma.
Topics: Adult; Animals; Brain Neoplasms; Bromodeoxyuridine; Clinical Trials as Topic; Combined Modality Therapy; Cornea; Eye Diseases; Follow-Up Studies; Glioma; Humans; Infusion Pumps, Implantable; Macaca mulatta; Male; Middle Aged; Radiotherapy | 1990 |
109 other study(ies) available for bromodeoxyuridine and Glioma
Article | Year |
---|---|
Dihydroartemisinin treatment exhibits antitumor effects in glioma cells through induction of apoptosis.
Topics: Animals; Apoptosis; Artemisinins; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; G1 Phase; G2 Phase; Glioma; Humans; Rats; Reactive Oxygen Species | 2017 |
Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells.
Topics: AC133 Antigen; Amphotericin B; Analysis of Variance; Animals; Annexin A5; Antigens, CD; Antineoplastic Agents; Brain Neoplasms; Bromodeoxyuridine; Calcium-Binding Proteins; Cell Cycle; Cell Differentiation; Chemokine CCL2; Coculture Techniques; Culture Media, Conditioned; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Flow Cytometry; Gene Expression Profiling; Glioma; Glycoproteins; Humans; Interleukin-1; Kaplan-Meier Estimate; Macrophages; Magnetic Resonance Imaging; Mice; Microfilament Proteins; Microglia; Neoplasm Transplantation; Nerve Tissue Proteins; Nitric Oxide Synthase Type II; Oligonucleotide Array Sequence Analysis; Peptides; Receptors, CCR2; RNA, Messenger; RNA, Small Interfering; Time Factors; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2014 |
The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype.
Topics: Analysis of Variance; Animals; Arginase; Bromodeoxyuridine; Cell Proliferation; Cells, Cultured; Cerebral Cortex; Culture Media, Conditioned; Enzyme Inhibitors; Glioma; Interferon-alpha; Lipopolysaccharides; Neuroglia; Nitric Oxide Synthase Type II; Phosphorylation; Rats; RNA, Messenger; Time Factors; TOR Serine-Threonine Kinases | 2014 |
Multiparametric Cell Cycle Analysis Using the Operetta High-Content Imager and Harmony Software with PhenoLOGIC.
Topics: Algorithms; Bromodeoxyuridine; Cell Cycle; Cell Proliferation; DNA; Flow Cytometry; Glioma; HT29 Cells; Humans; Microscopy; Software; Tumor Cells, Cultured | 2015 |
Indirect radio-chemo-beta therapy: a targeted approach to increase biological efficiency of x-rays based on energy.
Topics: Animals; Antimetabolites, Antineoplastic; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Combined Modality Therapy; DNA Repair; Flow Cytometry; Glioma; Methotrexate; Photons; Radiation-Sensitizing Agents; Rats; X-Rays | 2015 |
Antiangiogenic effects of noscapine enhance radioresponse for GL261 tumors.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Female; Glioma; Humans; In Situ Nick-End Labeling; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Noscapine; Radiation Tolerance; Xenograft Model Antitumor Assays | 2008 |
The inhibitory effect of suramin on telomerase activity and spheroid growth of C6 glioma cells.
Topics: Animals; Bromodeoxyuridine; Cell Cycle; Cell Nucleolus; Cell Proliferation; DNA, Neoplasm; Glioma; Rats; Spheroids, Cellular; Suramin; Telomerase; Time Factors; Tumor Cells, Cultured | 2008 |
Bromodeoxyuridine inhibits cancer cell proliferation in vitro and in vivo.
Topics: Administration, Oral; Animals; Bromodeoxyuridine; Cell Cycle; Cell Proliferation; Disease Progression; Glioma; Humans; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Neoplasms, Experimental; Nucleosides; Rats; Rats, Inbred F344; Time Factors; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2008 |
Valproic acid induces polarization, neuronal-like differentiation of a subpopulation of C6 glioma cells and selectively regulates transgene expression.
Topics: Animals; beta-Galactosidase; Bromodeoxyuridine; Cell Death; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Polarity; Cell Proliferation; Colforsin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Glioma; Green Fluorescent Proteins; Histones; L-Lactate Dehydrogenase; Mice; Neurons; Thy-1 Antigens; Time Factors; Transduction, Genetic; Valproic Acid | 2008 |
Inhibition of rat glioma cell migration and proliferation by a calix[8]arene scaffold exposing multiple GlcNAc and ureido functionalities.
Topics: Analysis of Variance; Animals; Benzimidazoles; Bromodeoxyuridine; Calixarenes; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclopentanes; Enzyme Activation; Focal Adhesion Kinase 1; Glioma; N-Acetylgalactosaminyltransferases; Rats; Tetrazolium Salts; Thiazoles; Time Factors; Wounds and Injuries | 2008 |
Thrombin enhances glioma growth.
Topics: Animals; Anticoagulants; Arginine; Behavior, Animal; Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Functional Laterality; Glioma; Hemostatics; Male; Neoplasm Transplantation; Pipecolic Acids; Rats; Rats, Inbred F344; Sulfonamides; Tetrazolium Salts; Thiazoles; Thrombin; Time Factors | 2008 |
PPARgamma and RXRgamma ligands act synergistically as potent antineoplastic agents in vitro and in vivo glioma models.
Topics: Analysis of Variance; Animals; Annexin A5; Antineoplastic Agents; bcl-2-Associated X Protein; Brain Neoplasms; Bromodeoxyuridine; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Regulation, Neoplastic; Glioma; Humans; Ligands; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Pioglitazone; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Rats; Retinoid X Receptor gamma; Tetrazolium Salts; Thiazoles; Thiazolidinediones; Transfection; Tretinoin; Tumor Stem Cell Assay | 2009 |
Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis.
Topics: Animals; Brain; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cell Line; Depression; Disease Models, Animal; Doublecortin Domain Proteins; Exploratory Behavior; Food Preferences; Glioma; Humans; Locomotion; Male; Maze Learning; Microinjections; Microtubule-Associated Proteins; Neurogenesis; Neuropeptides; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Statistics, Nonparametric; Sucrose; Sweetening Agents; Swimming; Transfection | 2010 |
Reciprocal effects of conditioned medium on cultured glioma cells and neural stem cells.
Topics: Animals; Animals, Newborn; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Corpus Striatum; Culture Media, Conditioned; Embryo, Mammalian; Glioma; Hippocampus; Humans; Mice; Nerve Tissue Proteins; Neurons; Stem Cells; Tetrazolium Salts; Thiazoles | 2009 |
Construction of a ganciclovir-sensitive lentiviral vector to assess the influence of angiopoietin-3 and soluble Tie2 on glioma growth.
Topics: Analysis of Variance; Angiopoietin-Like Protein 1; Angiopoietin-like Proteins; Angiopoietins; Animals; Antiviral Agents; Bromodeoxyuridine; Cell Growth Processes; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Ganciclovir; Gene Expression Regulation, Neoplastic; Genetic Vectors; Glioma; Green Fluorescent Proteins; Humans; Male; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Receptor, TIE-2; Transduction, Genetic; Transfection | 2010 |
Stereological analysis on migration of human neural stem cells in the brain of rats bearing glioma.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Functional Laterality; Glioma; Humans; Neurons; Rats; Rats, Sprague-Dawley; Stem Cells; Stereotaxic Techniques; Time Factors | 2010 |
Activation of PKC-alpha is required for migration of C6 glioma cells.
Topics: Animals; Antimetabolites; Blotting, Western; Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Movement; Enzyme Activation; Glioma; Immunohistochemistry; In Situ Nick-End Labeling; Protein Kinase C-alpha; Protein Kinase Inhibitors; Rats | 2010 |
Retroviral delivery of platelet-derived growth factor to spinal cord progenitor cells drives the formation of intramedullary gliomas.
Topics: Animals; Antigens; Basic Helix-Loop-Helix Transcription Factors; Bromodeoxyuridine; Cell Proliferation; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Glial Fibrillary Acidic Protein; Glioma; Green Fluorescent Proteins; Nerve Tissue Proteins; Oligodendrocyte Transcription Factor 2; Platelet-Derived Growth Factor; Proteoglycans; Rats; Rats, Inbred F344; Receptor, Platelet-Derived Growth Factor alpha; Retroviridae; Spinal Cord Neoplasms; Stem Cells; Time Factors | 2012 |
Perillyl alcohol as a radio-/chemosensitizer in malignant glioma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Bromodeoxyuridine; Cell Death; Cell Line; Cell Line, Tumor; Cisplatin; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Doxorubicin; Fas Ligand Protein; fas Receptor; G2 Phase; Genes, Dominant; Glioma; Humans; Membrane Glycoproteins; Mitosis; Monoterpenes; Protein Structure, Tertiary; Radiation-Sensitizing Agents; Rats; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Transfection; Up-Regulation | 2003 |
In vitro synchronization of mammalian astrocytic cultures by serum deprivation.
Topics: Animals; Animals, Newborn; Astrocytes; Bromodeoxyuridine; Cell Cycle; Cells, Cultured; Culture Media, Serum-Free; DNA Replication; Fluorescent Antibody Technique; G1 Phase; Glioma; In Vitro Techniques; Kinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; S Phase; Sensitivity and Specificity; Thymidine; Time Factors; Tritium; Tumor Cells, Cultured | 2003 |
Perinecrotic glioma proliferation and metabolic profile within an intracerebral tumor xenograft.
Topics: Animals; Blotting, Western; Brain; Brain Neoplasms; Bromodeoxyuridine; Cell Differentiation; Cell Division; Electron Transport Complex IV; Excitatory Amino Acid Transporter 2; Glioma; Glycogen Phosphorylase; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; L-Lactate Dehydrogenase; Male; Microscopy, Confocal; Neoplasm Transplantation; Neovascularization, Pathologic; Rats; Rats, Wistar; Staining and Labeling; Succinic Acid; Time Factors; Transcription Factors; Transplantation, Heterologous; Tumor Cells, Cultured | 2004 |
Treatment of intracranial rat glioma model with implant of radiosensitizer and biomodulator drug combined with external beam radiotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Combined Modality Therapy; Drug Combinations; Drug Implants; Fluorouracil; Glioma; Immunologic Factors; Methotrexate; Phosphonoacetic Acid; Radiation-Sensitizing Agents; Rats | 2004 |
The mitogen-activated/extracellular signal-regulated kinase kinase 1/2 inhibitor U0126 induces glial fibrillary acidic protein expression and reduces the proliferation and migration of C6 glioma cells.
Topics: Analysis of Variance; Animals; Blotting, Western; Bromodeoxyuridine; Butadienes; Caspase 3; Cell Count; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression; Glial Fibrillary Acidic Protein; Glioma; Immunohistochemistry; Mice; Nitriles; Tetrazolium Salts; Thiazoles | 2006 |
A cellular automaton model for the migration of glioma cells.
Topics: Algorithms; Animals; Bromodeoxyuridine; Cell Communication; Cell Movement; Cell Proliferation; Computer Simulation; Extracellular Matrix; Glioma; Humans; Kinetics; Models, Biological; Spheroids, Cellular; Swine; Tumor Cells, Cultured | 2006 |
Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
Topics: Administration, Oral; Animals; Apoptosis; bcl-2-Associated X Protein; Brain Neoplasms; Bromodeoxyuridine; Caspase 3; Cell Proliferation; Cell Survival; DNA, Neoplasm; Glioma; Humans; Ki-67 Antigen; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplasms, Experimental; Pioglitazone; PPAR gamma; Rats; Rats, Sprague-Dawley; Thiazolidinediones; Treatment Outcome; Tumor Burden | 2006 |
Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Brain Neoplasms; Bromodeoxyuridine; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chromatin Immunoprecipitation; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Embryo, Mammalian; Flow Cytometry; Glioma; Green Fluorescent Proteins; Luciferases; Mice; Mice, Inbred C57BL; Mice, SCID; Mice, Transgenic; Nerve Tissue Proteins; Neurons; Oligodendrocyte Transcription Factor 2; Stem Cells | 2007 |
Potassium channel blockers quinidine and caesium halt cell proliferation in C6 glioma cells via a polyamine-dependent mechanism.
Topics: Animals; Bromodeoxyuridine; Calcium; Cell Cycle; Cell Division; Cell Line, Tumor; Cesium; Glioma; Kinetics; L-Lactate Dehydrogenase; Ornithine Decarboxylase; Potassium Channel Blockers; Quinidine; Rats | 2007 |
Characterization of the subventricular zone neurogenic response to rat malignant brain tumors.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cell Count; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Transplantation; Cerebral Ventricles; Doublecortin Domain Proteins; Doublecortin Protein; Gene Expression Regulation, Neoplastic; Glioma; Intermediate Filament Proteins; Ki-67 Antigen; Luminescent Proteins; Microtubule-Associated Proteins; Nerve Tissue Proteins; Nestin; Neural Cell Adhesion Molecule L1; Neurons; Neuropeptides; Rats; Rats, Inbred F344; Sialic Acids; Time Factors | 2007 |
Elevation of osteopontin levels in brain tumor cells reduces burden and promotes survival through the inhibition of cell dispersal.
Topics: Animals; Apoptosis; Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glioblastoma; Glioma; Green Fluorescent Proteins; Humans; In Situ Nick-End Labeling; Osteopontin; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Survival Analysis; Time Factors; Transfection; Transplants | 2008 |
Potentiation of cytotoxicity by combination of imatinib and chlorimipramine in glioma.
Topics: Animals; Annexin A5; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Clomipramine; Cyclic AMP; Drug Synergism; Glioma; Imatinib Mesylate; Microscopy, Electron, Scanning; Piperazines; Pyrimidines; Rats | 2008 |
[Radiosensitizers for brain tumors--study of radiotherapy].
Topics: Adolescent; Adult; Antimetabolites; Brain Neoplasms; Bromodeoxyuridine; Child; Culture Techniques; Ependymoma; Female; Glioma; Humans; Infusions, Parenteral; Male; Meningioma; Radiation-Sensitizing Agents | 1967 |
Incorporation and metabolism of exogenous fatty acids by cultured normal and tumoral glial cells.
Topics: Animals; Animals, Newborn; Astrocytes; Brain; Brain Neoplasms; Bromodeoxyuridine; Bucladesine; Carbon Radioisotopes; Cells, Cultured; Cricetinae; Fatty Acids, Nonesterified; Glioma; Kinetics; Neoplasms, Experimental; Neuroglia; Rats | 1983 |
Phase I study of intravenous bromodeoxyuridine used concomitantly with radiation therapy in patients with primary malignant brain tumors.
Topics: Adult; Aged; Brain Neoplasms; Bromodeoxyuridine; Drug Evaluation; Female; Glioma; Humans; Injections, Intravenous; Male; Middle Aged; Radiation-Sensitizing Agents | 1984 |
Pharmacological evaluation of intravenous delivery of 5-bromodeoxyuridine to patients with brain tumors.
Topics: Brain Neoplasms; Bromodeoxyuridine; Drug Administration Schedule; Glioma; Humans; Infusions, Parenteral; Kinetics | 1984 |
Effect of mitochondrial DNA transmitted cytoplasmically from nontumorigenic to tumorigenic rat cells on the phenotypic expression of tumorigenicity.
Topics: Animals; Bromodeoxyuridine; Cell Line; Chloramphenicol; DNA, Mitochondrial; Drug Resistance; Glioma; Karyotyping; Male; Mice; Mice, Nude; Phenotype; Rats; Teratoma; Transfection | 1984 |
Proliferating cell nuclear antigen expression in rat glioma model: comparison with bromodeoxyuridine labeling index.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Female; Glioma; Nuclear Proteins; Pregnancy; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar | 1994 |
Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.
Topics: Adult; Affinity Labels; Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; Epitopes; Female; Glioblastoma; Glioma; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Neoplasm Proteins; Nuclear Proteins; Paraffin Embedding; Regression Analysis; S Phase | 1994 |
alpha-Difluoromethylornithine increases the anti-tumor effect of cis-diamminedichloroplatinum in G-XII rat glioma.
Topics: Acetyltransferases; Animals; Brain; Brain Neoplasms; Bromodeoxyuridine; Cell Movement; Cells, Cultured; Cisplatin; Culture Techniques; Drug Synergism; Drug Therapy, Combination; Eflornithine; Glioma; Ornithine Decarboxylase; Rats | 1995 |
Differential modification of radiation damage in 5-bromo-2-deoxy-uridine sensitized human glioma cells and PHA-stimulated peripheral leukocytes by 2-deoxy-D-glucose.
Topics: Adult; Bromodeoxyuridine; Cells, Cultured; Deoxyglucose; Glioma; Humans; Leukocytes; Male; Phytohemagglutinins; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1994 |
Bromodeoxyuridine-mediated radiosensitization in human glioma: the effect of concentration, duration, and fluoropyrimidine modulation.
Topics: Animals; Bromodeoxyuridine; Floxuridine; Glioma; Humans; In Vitro Techniques; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Radiation-Sensitizing Agents; Transplantation, Heterologous; Tumor Cells, Cultured | 1994 |
Selective enhancement by an antiviral agent of the radiation-induced cell killing of human glioma cells transduced with HSV-tk gene.
Topics: Antiviral Agents; Bromodeoxyuridine; Cell Survival; Genetic Therapy; Glioma; Humans; Radiation Tolerance; Radiation-Sensitizing Agents; Simplexvirus; Thymidine Kinase; Transfection | 1994 |
The prognostic implications of histologic classification and bromodeoxyuridine labeling index of mixed gliomas.
Topics: Adolescent; Adult; Astrocytes; Brain Neoplasms; Bromodeoxyuridine; Child; Child, Preschool; Female; Glioma; Humans; Immunohistochemistry; Infant; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglia; Prognosis; Survival Analysis | 1994 |
Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells.
Topics: Animals; Astrocytes; Axons; Brain Neoplasms; Bromodeoxyuridine; Cell Transplantation; Glioma; Immunohistochemistry; Male; Microinjections; Microscopy, Electron; Myelin Sheath; Neoplasm Invasiveness; Neoplasm Transplantation; Phenotype; Rats; Rats, Wistar; Tumor Cells, Cultured | 1993 |
Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities.
Topics: Adult; Aged; Bromodeoxyuridine; Cell Division; Child; Female; Glioma; Humans; Male; Middle Aged; Prognosis; Supratentorial Neoplasms; Survival Rate; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1993 |
Halogenated pyrimidine sensitization of low dose rate irradiation in human malignant glioma.
Topics: Bromodeoxyuridine; Dose-Response Relationship, Radiation; Glioma; Humans; In Vitro Techniques; Radiation-Sensitizing Agents; Radiotherapy Dosage; Survival Rate; Tumor Cells, Cultured | 1993 |
Restriction endonuclease recognition and southern hybridization of bromodeoxyuridine-substituted genomic DNA.
Topics: Base Sequence; Blotting, Southern; Bromodeoxyuridine; DNA; DNA Restriction Enzymes; Genome; Glioma; Humans; Molecular Sequence Data; Nucleic Acid Hybridization; Tumor Cells, Cultured | 1993 |
Proliferation markers in gliomas: a comparison of BUDR, KI-67, and MIB-1.
Topics: Biomarkers, Tumor; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Coloring Agents; Glioma; Humans; Ki-67 Antigen; Linear Models; Neoplasm Proteins; Nuclear Proteins; Prospective Studies; Reproducibility of Results; Retrospective Studies | 1995 |
Effect of hyperthermia on cyclin B expression in a human glioblastoma cell line.
Topics: Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; CDC2 Protein Kinase; Cell Cycle; Cyclins; DNA, Neoplasm; Flow Cytometry; Glioma; Humans; Hyperthermia, Induced; Immunohistochemistry; Protein Binding; Tumor Cells, Cultured | 1995 |
Identification of resting cells by dual-parameter flow cytometry of statin expression and DNA content.
Topics: 3T3 Cells; Animals; Antigens, Neoplasm; Apoptosis; Biomarkers; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle Proteins; Cell Division; Cell Line, Transformed; DNA, Neoplasm; Estrogen Antagonists; Estrogens; Female; Fixatives; Flow Cytometry; Fluorescent Antibody Technique; Formaldehyde; Gene Expression; Glioma; Humans; Ki-67 Antigen; Mice; Neoplasm Proteins; Nuclear Proteins; Polymers; Proliferating Cell Nuclear Antigen; Propidium; Proteins; Rats; Resting Phase, Cell Cycle; Tamoxifen; Thymus Gland | 1995 |
The sequential changes in DNA synthesis, glucose utilization, protein synthesis, and peripheral benzodiazepine receptor density in C6 brain tumors after chemotherapy to predict the response of tumors to chemotherapy.
Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Bromodeoxyuridine; Carmustine; DNA; Female; Glioma; Glucose; Immunohistochemistry; Monitoring, Physiologic; Protein Biosynthesis; Rats; Rats, Wistar; Receptors, GABA-A | 1996 |
Cell proliferation and ploidy of human solid tumours: methodological experience with in vivo bromodeoxyuridine and DNA flow cytometry.
Topics: Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Feasibility Studies; Female; Flow Cytometry; Gastrointestinal Neoplasms; Glioma; Head and Neck Neoplasms; Humans; Neoplasms; Ovarian Neoplasms; Ploidies; Uterine Neoplasms | 1996 |
[The combined effect of hyperthermia and irradiation on cultured human glioma cell line].
Topics: Antigens, Neoplasm; Bromodeoxyuridine; Combined Modality Therapy; Glioma; Humans; Hyperthermia, Induced; Immunohistochemistry; Male; Proliferating Cell Nuclear Antigen; Radiotherapy; Tumor Cells, Cultured | 1996 |
Assessment of laminin-mediated glioma invasion in vitro and by glioma tumors engrafted within rat spinal cord.
Topics: Animals; Blotting, Western; Bromodeoxyuridine; Carrier Proteins; Cell Adhesion; Cell Movement; Disease Models, Animal; Glioma; Immunohistochemistry; Integrin beta1; Laminin; Magnetic Resonance Spectroscopy; Mice; Microinjections; Neoplasm Invasiveness; Neoplasm Transplantation; Nerve Fibers; Nerve Tissue Proteins; Neuroglia; Rats; Spinal Cord Neoplasms; Tumor Cells, Cultured | 1996 |
A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antigens, Nuclear; Biomarkers, Tumor; Brain Neoplasms; Bromodeoxyuridine; Cell Survival; Female; Glioma; Humans; Ki-67 Antigen; Life Tables; Male; Middle Aged; Multivariate Analysis; Nuclear Proteins; Prognosis; Proliferating Cell Nuclear Antigen; Proportional Hazards Models; Prospective Studies | 1997 |
S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors.
Topics: Aneuploidy; Antimetabolites; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Diploidy; DNA, Neoplasm; Flow Cytometry; Glioma; Humans; Meningioma; Oligodendroglioma; Ploidies; S Phase | 1997 |
Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma mult
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Analysis of Variance; Antimetabolites, Antineoplastic; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Female; Glioblastoma; Glioma; Humans; Karnofsky Performance Status; Male; Middle Aged; Proportional Hazards Models; Radiation-Sensitizing Agents; Regression Analysis; Retrospective Studies | 1998 |
Inhibition of growth and induction of differentiation of glioma cell lines by oncostatin M (OSM).
Topics: Antibodies; Bromodeoxyuridine; Cell Differentiation; Cell Division; Cell Size; Cytokines; DNA; Gene Expression Regulation, Neoplastic; Genes, fos; Glioma; Growth Inhibitors; Humans; Interleukin-6; Leukemia Inhibitory Factor; Lymphokines; Oncostatin M; Peptides; Phosphorylation; Phosphotyrosine; Tumor Cells, Cultured | 1998 |
Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner.
Topics: Alternative Splicing; Bromodeoxyuridine; Cell Cycle; Cell Cycle Proteins; Cell Division; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; Flow Cytometry; G1 Phase; Gene Expression Regulation; Genes, p53; Glioma; Humans; Immunoblotting; Microtubule-Associated Proteins; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins; Resting Phase, Cell Cycle; Retinoblastoma Protein; Transfection; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1998 |
Estimation of volume doubling time and cell loss in an experimental rat glioma model in vivo.
Topics: Animals; Apoptosis; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Glioma; Immunohistochemistry; In Situ Nick-End Labeling; Kinetics; Magnetic Resonance Imaging; Rats; Rats, Wistar; Time Factors | 1998 |
Final report on the University of California-San Francisco experience with bromodeoxyuridine labeling index as a prognostic factor for the survival of glioma patients.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Brain Neoplasms; Bromodeoxyuridine; Clinical Trials as Topic; Follow-Up Studies; Glioma; Humans; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prognosis; Proportional Hazards Models; San Francisco; Time Factors | 1999 |
Sensitization of 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin cytotoxicity by 5-bromo-2'-deoxyuridine in human glioma.
Topics: Bromodeoxyuridine; Carmustine; Cell Survival; DNA Damage; DNA, Neoplasm; Drug Synergism; Glioma; Humans; Kinetics; Tumor Cells, Cultured | 1999 |
A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading.
Topics: Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Diagnosis, Computer-Assisted; Female; Glioma; Humans; Male; Neoplasm Staging; Prognosis; World Health Organization | 1999 |
Prognostic relevance of MIB-1 immunoreactivity, S-phase fraction, 5-bromo-2'-deoxyuridine labeling indices, and mitotic figures in gliomas.
Topics: Adult; Aged; Antigens, Nuclear; Brain Neoplasms; Bromodeoxyuridine; Disease-Free Survival; DNA, Neoplasm; Female; Flow Cytometry; Glioma; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Male; Middle Aged; Mitosis; Mitotic Index; Nuclear Proteins; Prognosis; Retrospective Studies; S Phase | 1999 |
Glial cell line-derived neurotrophic factor (GDNF) is a proliferation factor for rat C6 glioma cells: evidence from antisense experiments.
Topics: Animals; Blotting, Western; Bromodeoxyuridine; Cation Exchange Resins; Cell Count; Cell Division; Cell Survival; Central Nervous System; Drosophila Proteins; Enzyme-Linked Immunosorbent Assay; Genetic Therapy; Glial Cell Line-Derived Neurotrophic Factor; Glial Cell Line-Derived Neurotrophic Factor Receptors; Glioma; Lipid Metabolism; Lipids; Liposomes; Nerve Growth Factors; Nerve Tissue Proteins; Oligonucleotides, Antisense; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Rats; Receptor Protein-Tyrosine Kinases; Transfection; Trypan Blue; Tumor Cells, Cultured | 2000 |
Human glioma cells expressing herpes simplex virus thymidine kinase gene treated with acyclovir, ganciclovir and bromovinyldeoxyuridine. Evaluation of their activity in vitro and in nude mice.
Topics: Acyclovir; Animals; Antiviral Agents; Blotting, Northern; Blotting, Western; Bromodeoxyuridine; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Ganciclovir; Genetic Therapy; Genetic Vectors; Glioma; Humans; Mice; Mice, Nude; Models, Chemical; Neoplasm Transplantation; Thymidine Kinase; Time Factors; Tumor Cells, Cultured | 2001 |
Co-transduction of Apaf-1 and caspase-9 highly enhances p53-mediated apoptosis in gliomas.
Topics: Adenoviridae; Apoptosis; Apoptotic Protease-Activating Factor 1; Brain Neoplasms; Bromodeoxyuridine; Caspase 9; Caspases; Cell Survival; fas Receptor; Flow Cytometry; Gene Expression; Glioma; Humans; Immunoblotting; Neuropeptides; Proteins; Receptors, Tumor Necrosis Factor; Transduction, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |
[Chemo-radiotherapy of brain tumors (author's transl)].
Topics: Brain Neoplasms; Bromodeoxyuridine; Glioma; Humans | 1976 |
Drug-induced differentiation of a rat glioma in vitro: II. the expression of S-100, a glial specific protein and steroid sulfatase.
Topics: Animals; Bromodeoxyuridine; Cell Division; Cells, Cultured; DNA Replication; Glioma; In Vitro Techniques; Methotrexate; Neoplasm Proteins; Rats; Steroids; Sulfatases; Time Factors | 1978 |
Proliferative potential and outcome in pediatric astrocytic tumors.
Topics: Adolescent; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Child; Child, Preschool; Combined Modality Therapy; Female; Glioblastoma; Glioma; Humans; Infant; Male; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome | 1992 |
Modulation of BUdR labeling index in rat brain tumors following intracarotid ACNU administration.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Carotid Arteries; Cell Division; Dose-Response Relationship, Drug; Glioma; Injections, Intra-Arterial; Neoplasm Transplantation; Nimustine; Rats; Time Factors; Tumor Cells, Cultured | 1992 |
[Proliferation kinetics of human brain tumors by in situ double labeling with bromodeoxyuridine and iododeoxyuridine].
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Division; Child; Child, Preschool; Female; Glioma; Humans; Idoxuridine; Male; Meningeal Neoplasms; Meningioma; Middle Aged; S Phase | 1992 |
Decrease in TTP pools mediated by 5-bromo-2'-deoxyuridine exposure in a human glioblastoma cell line.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Culture Media; Deoxyuracil Nucleotides; DNA, Neoplasm; Glioma; Humans; Thymine Nucleotides; Tumor Cells, Cultured | 1992 |
Systemic treatment with murine recombinant interleukin-1 beta inhibits the growth and progression of malignant glioma in the rat.
Topics: Animals; Bromodeoxyuridine; Cell Division; Cell Line; Female; Glioma; Interleukin-1; Mice; Rats; Rats, Inbred F344; Recombinant Proteins | 1992 |
Correlation between nucleolar organizer region score and bromodeoxyuridine labeling index in C6 glioma cell line.
Topics: Animals; Bromodeoxyuridine; Bucladesine; Cell Differentiation; Cell Division; Culture Media; Glioma; Nucleolus Organizer Region; Rats; Rats, Inbred Strains; Silver Staining; Tumor Cells, Cultured | 1991 |
Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Capillary Permeability; Cell Division; Copper; Diet; Fibronectins; Glioma; Lung Neoplasms; Neovascularization, Pathologic; Penicillamine; Rabbits; Rats | 1990 |
Cell kinetic analysis of human brain tumors by in situ double labelling with bromodeoxyuridine and iododeoxyuridine.
Topics: Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Glioma; Humans; Idoxuridine; Meningioma | 1992 |
[Evaluation of 201Tl SPECT in patients with glioma: a comparative study with histological diagnosis, clinical feature and proliferative activity].
Topics: Adult; Aged; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Female; Glioma; Humans; Male; Middle Aged; Predictive Value of Tests; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1991 |
Variability of 5-bromo-2'-deoxyuridine incorporation into DNA of human glioma cell lines and modulation with fluoropyrimidines.
Topics: Bromodeoxyuridine; DNA, Neoplasm; Floxuridine; Fluorouracil; Glioma; Humans; Tumor Cells, Cultured | 1991 |
A three-dimensional micro-organ culture system optimized for in vitro growth of human malignant brain tumors.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Carmustine; Cell Survival; Glioma; Humans; Immunohistochemistry; Macrophages; Mice; Mice, Nude; Neoplasm Transplantation; Tumor Cells, Cultured | 1991 |
[New development in clinicopathological diagnosis of brain tumors].
Topics: Brain Neoplasms; Bromodeoxyuridine; Cell Division; Glioma; Humans; Neoplasm Invasiveness | 1991 |
Correlation between bromodeoxyuridine-labeling indices and patient prognosis in cerebral astrocytic tumors of adults.
Topics: Adult; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Follow-Up Studies; Glioma; Humans; Neoplasm Recurrence, Local; Prognosis; Survival Rate | 1991 |
Relationship of invasiveness to proliferating activity and to cytoskeletal protein production in human neuroepithelial tumors maintained in an organ culture system: use of human cortex and dura as supporting matrices.
Topics: Brain Neoplasms; Bromodeoxyuridine; Cell Division; Cell Line; Cerebral Cortex; Dura Mater; Glial Fibrillary Acidic Protein; Glioma; Humans; Intermediate Filament Proteins; Medulloblastoma; Neoplasm Invasiveness; Neurofilament Proteins; Organ Culture Techniques | 1990 |
Random sampling by glitter drop method.
Topics: Bromodeoxyuridine; Cell Count; Glioma; Humans; Random Allocation; Research Design; Specimen Handling | 1990 |
Rapid estimation of the proliferating index of brain tumours.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Bromodeoxyuridine; Cell Count; Cell Division; Female; Glioma; Humans; Immunohistochemistry; Male; Meningioma; Middle Aged | 1990 |
Cell kinetics of rat 9L brain tumors determined by double labeling with iodo- and bromodeoxyuridine.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; DNA, Neoplasm; Glioma; Idoxuridine; Rats; Tumor Cells, Cultured | 1990 |
Cell-kinetic characteristics of human brain tumors.
Topics: Adult; Aged; Brain Neoplasms; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Female; Flow Cytometry; Glioma; Humans; Kinetics; Male; Meningeal Neoplasms; Meningioma; Middle Aged | 1990 |
[Growth fraction of human central nervous system tumors measured by using bromodeoxyuridine].
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Division; Child; Female; Glioma; Humans; Male; Middle Aged | 1987 |
Cell kinetics of intracerebrally implanted RG-C6 tumors in rats--effects of intracarotid hyperosmolar mannitol measured by 3H-thymidine autoradiography and bromodeoxyuridine uptake.
Topics: Animals; Autoradiography; Brain Neoplasms; Bromodeoxyuridine; Carotid Artery, Internal; Cell Cycle; Glioma; Hypertonic Solutions; Infusions, Intra-Arterial; Male; Mannitol; Neoplasm Transplantation; Rats; Rats, Inbred Strains; Thymidine; Tritium | 1988 |
Cell cycle phase dependent emergence of thymidylate synthase studied by monoclonal antibody (M-TS-4).
Topics: Antibodies, Monoclonal; Autoradiography; Bromodeoxyuridine; Cell Cycle; Cell Line; DNA; Flow Cytometry; Glioma; HeLa Cells; Humans; Immunoenzyme Techniques; Staining and Labeling; Thymidylate Synthase | 1989 |
[Therapeutic efficacy of intracarotid infusion of 20% mannitol with ACNU in Fischer rats with intracerebrally implanted 9L gliosarcoma].
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Bromodeoxyuridine; Carotid Artery, Internal; Cell Division; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Glioma; Infusions, Intra-Arterial; Infusions, Parenteral; Male; Mannitol; Neoplasm Transplantation; Nimustine; Rats; Rats, Inbred F344 | 1989 |
Variability in the proliferative potential of human gliomas.
Topics: Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Glioblastoma; Glioma; Humans; Interphase | 1989 |
[Histopathologic changes and tumor cell kinetics after hyperthermia and/or radiation therapy in a rat glioma model: bromodeoxyuridine (BUdR) labelling index].
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Combined Modality Therapy; Glioma; Hyperthermia, Induced; Neoplasm Transplantation; Rats; Rats, Inbred Strains | 1989 |
[A trial of ACNU and radiation therapy with sensitizing agents for malignant gliomas].
Topics: Acyclovir; Adolescent; Adult; Aged; Brain Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Evaluation Studies as Topic; Female; Glioma; Humans; Male; Middle Aged; Nimustine; Radiation Injuries; Radiation-Sensitizing Agents; Radiotherapy Dosage; Remission Induction; Vidarabine | 1989 |
Double labeling with iodo- and bromodeoxyuridine for cell kinetics studies.
Topics: Bromodeoxyuridine; Cell Cycle; Cell Division; Glioma; Humans; Idoxuridine; Immunoenzyme Techniques; Immunohistochemistry; Interphase; Kinetics; Tumor Cells, Cultured | 1989 |
Correlation of histopathological features and proliferative potential of gliomas.
Topics: Adult; Brain Neoplasms; Bromodeoxyuridine; Female; Glioma; Humans; Immunohistochemistry; Male; Necrosis | 1989 |
Prolongation of G1 phase in cultured glioma cells by cis-dichlorodiammineplatinum (II) (CDDP): analysis using bromodeoxyuridine (BrdU)-Hoechst technique.
Topics: Animals; Bromodeoxyuridine; Cell Cycle; Cell Line; Flow Cytometry; Glioma; Humans; Organoplatinum Compounds; Rats; Tumor Cells, Cultured | 1989 |
Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues.
Topics: Aged; Antibodies, Monoclonal; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Child, Preschool; Female; Glioblastoma; Glioma; Histocytochemistry; Humans; Immunochemistry; Interphase; Male; Meningioma; Middle Aged | 1985 |
Effect of interferon-beta on the cell cycle of human glioma cell line U-251 MG: flow cytometric two-dimensional (BrdU/DNA) analysis.
Topics: Bromodeoxyuridine; Cell Cycle; Cell Division; DNA, Neoplasm; Flow Cytometry; Glioma; Humans; Interferon Type I; Tumor Cells, Cultured | 1988 |
Treatment response in malignant optic glioma of adulthood.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Cranial Nerve Neoplasms; Female; Follow-Up Studies; Glioma; Humans; Lomustine; Male; Middle Aged; Neoplasm Invasiveness; Optic Nerve Diseases; Procarbazine; Vincristine | 1988 |
Cell cycle perturbation of cultured C6 glioma cells following short-term contact with a low dose of ACNU.
Topics: Animals; Bromodeoxyuridine; Cell Division; Cell Line; DNA, Neoplasm; Flow Cytometry; Glioma; Interphase; Kinetics; Mitosis; Nimustine; Nitrosourea Compounds; Rats | 1987 |
Cytotoxic effect and induction of sister chromatid exchange in exponentially growing rat 9L gliosarcoma cells after brief exposure to BrdU.
Topics: Animals; Bromodeoxyuridine; Cell Division; Glioma; Rats; Sister Chromatid Exchange; Tumor Cells, Cultured | 1987 |
[Effect of CDDP on cultured glioma cell lines: analysis of cell kinetics by flow cytometry].
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Line; Cells, Cultured; Cisplatin; Flow Cytometry; Glioma; Rats | 1986 |
High hydrostatic pressure and chromate-induced effects on cell cycle kinetics.
Topics: Animals; Bromodeoxyuridine; Cell Cycle; Cell Line; Chromates; Flow Cytometry; Glioma; Hydrostatic Pressure; Kinetics; Potassium Compounds; Pressure; Rats | 1987 |
In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Child; Child, Preschool; DNA; Ependymoma; Female; Glioma; Humans; Infant; Kinetics; Male; Medulloblastoma; Middle Aged | 1986 |
Radiosensitization of brain tumor cells with a thymidine analogue (bromouridine).
Topics: Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Culture Techniques; DNA; Floxuridine; Fluorouracil; Follow-Up Studies; Glioma; Humans; Meningioma; Methotrexate; Oligodendroglioma; Radiation-Sensitizing Agents; Thymidine | 1968 |
Adenosine 3',5'-monophosphate in glial tumor cells. Alterations by 5-bromodeoxyuridine.
Topics: Adenylyl Cyclases; Animals; Bromodeoxyuridine; Butyrates; Cell Line; Cell Transformation, Neoplastic; Culture Media; Cyclic AMP; Glioma; L-Lactate Dehydrogenase; Norepinephrine; Phosphoric Diester Hydrolases; Rats; Time Factors; Tritium | 1973 |
Stimulation of synthesis of free chondroitin sulfate chains by beta-D-xylosides in cultured cells.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Hepatocellular; Cartilage; Cell Line; Cells, Cultured; Chick Embryo; Chondroitin; Coumarins; Glioma; Glycosaminoglycans; Glycosides; Liver Neoplasms; Mice; Neuroblastoma; Puromycin; Rats; Stimulation, Chemical; Xylose | 1974 |
Influence of noradrenalin, prostaglandin E1 and inhibitors of phosphodiesterase activity on levels of the cyclic adenosine 3':5'-monophosphate in somatic cell hybrids.
Topics: Animals; Bromodeoxyuridine; Carbon Radioisotopes; Clone Cells; Cyclic AMP; Drug Resistance; Glioma; Hybrid Cells; Mice; Neuroblastoma; Norepinephrine; Papaverine; Phosphodiesterase Inhibitors; Prostaglandins; Rats; Time Factors; Xanthines | 1973 |
Drug-induced differentiation of a rat glioma in vitro.
Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Cell Line; Clone Cells; Dactinomycin; Desmosomes; Glioma; Glycogen; In Vitro Techniques; Methotrexate; Microscopy, Electron; Microscopy, Phase-Contrast; Rats; Stimulation, Chemical | 1972 |